THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $33,089,000 | +5.0% | 35,675,000 | +7.5% | 0.75% | +2.9% |
| Q1 2022 | $31,516,000 | -11.7% | 33,175,000 | -10.2% | 0.73% | -5.9% |
| Q4 2021 | $35,674,000 | -22.5% | 36,925,000 | -25.7% | 0.78% | -35.9% |
| Q3 2021 | $46,013,000 | +60.4% | 49,675,000 | +65.6% | 1.22% | +53.0% |
| Q2 2021 | $28,693,000 | +93.5% | 30,000,000 | +106.9% | 0.80% | +34.5% |
| Q1 2021 | $14,826,000 | -49.8% | 14,500,000 | -37.7% | 0.59% | +37.8% |
| Q1 2017 | $29,550,000 | -18.6% | 23,290,000 | -26.1% | 0.43% | -33.6% |
| Q4 2016 | $36,304,000 | – | 31,500,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 13,473,000 | $12,756,000 | 1.74% |
| Shaolin Capital Management LLC | 14,065,000 | $13,281,000 | 0.93% |
| ZAZOVE ASSOCIATES LLC | 3,773,000 | $3,584,000 | 0.44% |
| FARALLON CAPITAL MANAGEMENT LLC | 56,695,000 | $53,806,000 | 0.32% |
| Baupost Group | 30,000,000 | $28,396,000 | 0.26% |
| Aequim Alternative Investments LP | 3,000,000 | $2,840,000 | 0.21% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $22,817,000 | 0.17% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $5,257,000 | 0.15% |
| SSI INVESTMENT MANAGEMENT LLC | 1,750,000 | $1,648,000 | 0.12% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 430,000 | $406,000 | 0.06% |